Skip to search formSkip to main contentSkip to account menu

rilmenidine

Known as: 2-(N-(dicyclopropylmethyl)amino)oxazoline, 2-Oxazolamine, N-(dicyclopropylmethyl)-4,5-dihydro-, oxaminozoline 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2006
2006
The aim of the present study was to evaluate effects of long-term treatment with rilmenidine compared with atenolol on lipid and… 
2005
2005
  • P. Box
  • 2005
  • Corpus ID: 148055680
Background: Heightened central sympathetic nervous outflow is common in essent ial hypertension, contributing to hypertension… 
2001
2001
Objective It has been suggested that imidazoline receptors rather than α2-adrenoceptors are involved in the sympathoinhibitory… 
2001
2001
BackgroundRilmenidine is a centrally-acting antihypertensive. At present, the dosage for rilmenidine is 1mg once a day, which in… 
1999
1999
Administration (3 to 100 microg/kg IV) of clonidine, rilmenidine, and an imidazoline derivative, 2-(2-chlorophenylamino… 
1993
1993
Summary: The responses of mean arterial pressure (MAP), heart rate (HR), and renal sympathetic nerve activity (RSNA) to… 
1989
1989
The effects of rilmenidine [(N-dicyclopropylmethyl) amino-2-oxazoline; S 3341], an α2 agonist, on the hypertensive rat heart have… 
1989
1989
Rilmenidine is an oxazoline with antihypertensive properties characterised by a dissociation of its antihypertensive and central…